C M Bidwell & Associates LTD Lannett CO Inc Transaction History

C M Bidwell & Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$8.49 - $12.81 $109,605 - $165,377	-12,910 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$5.58 - $14.47 $72,037 - $186,807	12,910 New	12,910 $145,000
Q1 2018 May 11, 2018	SELL	$14.7 - $24.95 $48,069 - $81,586	-3,270 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$19.9 - $29.25 $65,072 - $95,647	3,270	3,270 $76,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.